Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...
Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...
EU exports to the US reached $605.8 billion in 2024, according to the US Census Bureau. Pharmaceutical companies are particularly vulnerable, according to BI strategists Laurent Douillet and Kaidi ...
The number of measles cases in an outbreak in the South Plains region of northern Texas has grown from 24 illnesses to 48 in ...
The job losses at the CDC are part of a broader reduction of about 5,200 positions across other government public health ...
Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...
The pharmaceutical industry is preparing for ‘major disruptions’ following US President Donald Trump’s announcement on ...
Sanofi is reorganising its business units from seven to five in a bid to streamline its operations and ensure the success of its ambitious product launch plans. The revamp is the first major ...
Sanofi's rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused on developing a new generation of safer antibody-based therapies.
Seasonal flu vaccines need to be updated each year because the virus changes so frequently. But the U.S. hasn't contributed ...
Stoke Therapeutics’ stock climbed 8% early Tuesday, after the company and Biogen today announced a collaboration to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results